CoImmune, Inc. Appoints Ed Baracchini, PhD, Chairman of the Board of Directors
DURHAM, N.C., Nov. 15, 2021 (GLOBE NEWSWIRE) — CoImmune, Inc., a clinical stage immuno-oncology company working to redefine cancer treatment using best-in-class cellular immunotherapies, today